DKSH Holding AG, a leading provider of market expansion services, has announced a significant expansion in the realm of genomic healthcare by partnering with PacBio and Chulalongkorn University to launch "LIFE-SEQ," Asia's first genomic program for precision health. This initiative utilizes advanced HiFi genome sequencing technology to offer lifelong care starting from newborn screening and rare disease detection. As the exclusive distributor of PacBio in Thailand, DKSH is facilitating access to this cutting-edge technology and has assembled a team of genomics experts. In its initial phase, the program will provide free sequencing for 300 newborns at Chulalongkorn University's Faculty of Medicine, with plans to expand nationwide. This expansion marks a milestone in precision healthcare, aiming to deliver genomic benefits for people of all ages across Thailand.